Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Relapsed/Refractory Esophageal and Gastroesophageal Cancers
NCT00702884Phase 2Completed
- Start
- Jun 2008
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in esophageal carcinoma, gastroesophageal junction carcinoma (GEJ). Started Jun 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
esophageal carcinomagastroesophageal junction carcinoma (GEJ)
Beyond the preview
Go deeper on NCT00702884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702884.